Microbial limits for non-sterile chemical drugs, active pharmaceutical ingredients (API) and excipients were released in

Expedited safety reporting in drug clinical trials is a regulatory requirement in China that mandates

China drug standards draft measures have recently been released by the National Medical Products Administration

Drug recalls in China now designate market authorization holders (MAH) as the key responsible entity,